Barinthus Biotherapeutics plc
BRNS
$0.72
-$0.02-2.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.00% | -26.76% | -23.74% | -22.12% | -33.81% |
| Total Receivables | -76.72% | -11.52% | -39.66% | -10.08% | 256.88% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -23.39% | -18.73% | -1.61% | 8.46% | 56.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 374.78% | 346.01% | 13.19% | 41.25% | 30.70% |
| Total Current Assets | -35.55% | -23.86% | -23.23% | -19.86% | -21.28% |
|
|
|||||
| Total Current Assets | -35.55% | -23.86% | -23.23% | -19.86% | -21.28% |
| Net Property, Plant & Equipment | -63.76% | -57.05% | -46.91% | -39.40% | -8.00% |
| Long-term Investments | -- | -- | -- | -- | 0.00% |
| Goodwill | -- | -- | -- | -- | 0.00% |
| Total Other Intangibles | -34.43% | -13.44% | -13.00% | -12.59% | -12.21% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.32% | 6.55% | 1.92% | -0.11% | -12.23% |
| Total Assets | -42.13% | -30.62% | -28.82% | -25.26% | -17.95% |
|
|
|||||
| Total Accounts Payable | -77.31% | -29.58% | 16.78% | 54.53% | -40.21% |
| Total Accrued Expenses | -16.13% | -28.35% | -13.59% | 3.40% | -33.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.56% | 6.26% | 2.67% | 7.56% | 32.31% |
| Total Finance Division Other Current Liabilities | -31.41% | 81.76% | 1.88% | -- | -- |
| Total Other Current Liabilities | -31.41% | 81.76% | 1.88% | -- | -- |
| Total Current Liabilities | -28.36% | -18.37% | -6.69% | 24.28% | -18.83% |
|
|
|||||
| Total Current Liabilities | -28.36% | -18.37% | -6.69% | 24.28% | -18.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.58% | -6.59% | -8.61% | -9.87% | -4.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.50% | 18.49% | 19.66% | 19.51% | -24.43% |
| Total Liabilities | -15.70% | -9.61% | -3.87% | 9.75% | -14.95% |
|
|
|||||
| Common Stock & APIC | 0.35% | 0.87% | 1.34% | 1.78% | 1.60% |
| Retained Earnings | -34.95% | -33.22% | -33.96% | -34.59% | -36.30% |
| Treasury Stock & Other | -2.05% | 47.86% | 14.79% | -10.99% | 50.13% |
| Total Common Equity | -46.98% | -34.63% | -32.79% | -30.39% | -18.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.98% | -34.63% | -32.79% | -30.39% | -18.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -42.51% | -39.53% | -45.90% | -49.76% | -18.54% |
| Total Equity | -46.97% | -34.64% | -32.80% | -30.41% | -18.48% |
|
|
|||||